Vonaprument for Age-Related Macular Degeneration
(AiiM OLE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary purpose of the study is to assess the long term safety of intravitreal (IVT) injections of vonaprument.
Who Is on the Research Team?
Clinical Trials
Principal Investigator
Annexon, Inc.
Are You a Good Fit for This Trial?
This trial is for people with dry age-related macular degeneration who have geographic atrophy and previously participated in a related ANX007 study. Participants must meet certain health requirements set by the researchers.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Vonaprument
Trial Overview
The study is testing the long-term safety of vonaprument, given as injections into the eye, in people with this type of vision loss. All participants receive the treatment; there is no placebo group.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will receive vonaprument IVT injections every month for 24 months.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Annexon, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.